Improved sexual and urinary function in women with sacral nerve stimulation

Neuromodulation

Volumn 14, Issue 5, 2011, Pages 436-443

  Gill, Bradley C ^a,b   Swartz, Mia A ^c   Firoozi, Farzeen ^c   Rackley, Raymond R ^a,c   Moore, Courtenay K ^a,c   Goldman, Howard B ^a,c   Vasavada, Sandip P ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Case Western Reserve University   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bladder dysfunction; neurostimulation; sacral nerve stimulation; sexual function

Indexed keywords

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; PHYSICAL EXAMINATION; QUALITY OF LIFE; SACRAL NERVE STIMULATION; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; URGE INCONTINENCE; URINARY TRACT;

AGED; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MIDDLE AGED; PERIPHERAL NERVES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINATION;

EID: 80053562283     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2011.00380.x     Document Type: Article

References (36)

1. Gordon D, Groutz A, Sinai T, et al,. Sexual function in women attending a urogynecology clinic. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10: 325-328. (Pubitemid 29465399)
2. Yip SK, Chan A, Pang S, et al,. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol 2003; 188: 1244-1248. (Pubitemid 36589116)
3. Salonia A, Zanni G, Nappi RE, et al,. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross sectional study. Eur Urol 2004; 45: 642-648. (Pubitemid 38481693)
4. Patel A, O'Leary ML, Stein RJ, et al,. The relationship between overactive bladder and sexual activity in women. Int Braz J Urol 2006; 32: 77-87.
5. Sen I, Onaran M, Aksakal N, et al,. The impact of urinary incontinence on female sexual function. Adv Ther 2006; 23: 999-1008. (Pubitemid 46341057)
6. Handa VL, Cundiff G, Chang HH, Helzlsouer KJ,. Female sexual function and pelvic floor disorders. Obstet Gynecol 2008; 111: 1045-1052. (Pubitemid 351620336)
7. Cohen BL, Barboglio P, Gousse A,. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med 2008; 5: 1418-1423. (Pubitemid 351803107)
8. van Voskuilen AC, Oerlemans DJAJ, Weil EHJ, de Bie RA, van Kerrebroeck PE,. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 2006; 49: 366-372. (Pubitemid 43197883)
9. Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW,. Sacral nerve stimulation for voiding dysfunction: one institution's 11-year experience. Neurourol Urodyn 2007; 26: 19-28. (Pubitemid 46175442)
10. Vasavada SP, Goldman HB, Rackley RR,. Neuromodulation techniques: a comparison of available and new therapies. Curr Bladder Dysfunct Rep 2008; 3: 35-40.
11. Bernstein AJ, Peters KM,. Expanding indications for neuromodulation. Urol Clin North Am 2005; 32: 59-63. (Pubitemid 40215132)
12. Siegel S, Paszkiewicz E, Kirkpatrick C, Hinkel B, Oleson K,. Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001; 166: 1742-1745. (Pubitemid 32953399)
13. Comiter CV,. Sacral nerve stimulation to treat nonobstructive urinary retention in women. Curr Urol Rep 2008; 9: 405-411.
14. Brazzelli M, Murray A, Fraser C,. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol 2006; 175: 835-841. (Pubitemid 43199992)
15. Spinelli M, Sievert K-D,. Latest technologic and surgical developments in using InterStim⢠therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 2008; 54: 1287-1296.
16. Siddiqui NY, WU JM, Amundsen CL,. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn 2010; 29: S18-S23.
17. Pauls RN, Marinkovic SP, Silva WA, Rooney CM, Kleeman SD, Karram MM,. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 391-395. (Pubitemid 46390131)
18. Lombardi G, Mondaini N, Macchiarella A, Cilotti A, Del Popolo G,. Clinical female sexual outcome after sacral neuromodulation implant for lower urinary tract symptoms (LUTS). J Sex Med 2008; 5: 1411-1417. (Pubitemid 351803106)
19. Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV,. The effects of bilateral caudal epidural S2-4 neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 697-700. (Pubitemid 351516947)
20. Ingber MS, Ibrahim IA, Killinger KA, Diokno AC, Peters KM,. Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit? Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 1055-1059.
21. Rosen R, Brown C, Heiman J, et al,. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Maritial Ther 2000; 26: 191-208. (Pubitemid 30194541)
22. Meston CM,. Validation of the female sexual function index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003; 29: 39-46. (Pubitemid 36077807)
23. Wiegel M, Meston C, Rosen R,. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 32: 1-20. (Pubitemid 40070592)
24. Silva WA, Pauls RN, Segal JL, Rooney CM, Kleeman SD, Karram MM,. Uterosacral ligament valut suspension: five year outcomes. Obstet Gynecol 2006; 108: 255-263. (Pubitemid 44305664)
25. Yalcin I, Bump RC,. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003; 189: 98-101. (Pubitemid 36886531)
26. Yalcin I, Viktrup L,. Comparison of physician and patient assessments of incontinence severity and improvement. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 1291-1295. (Pubitemid 47521472)
27. Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H,. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health 1993; 47: 497-499. (Pubitemid 24016873)
28. Sandvik H, Seim A, Vanvik A, Hunskaar S,. A severity index for epidemiological surveys of female urinary incontinenceâcomparison with 48-hour pad weighing tests. Neurourol Urodyn 2000; 19: 137-145. (Pubitemid 30124033)
29. Barber MD, Walters MD, Bump RC,. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005; 193: 101-113.
30. Ubersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA,. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn 1995; 14: 131-139.
31. Shaker HS, Hassouna MM,. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol 1998; 159: 1516-1519. (Pubitemid 29117332)
32. Pauls RN, Silva WA, Rooney CM, et al,. Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2007; 197: 622.e1-622.e7.
33. Snedecor GW, Cochran WG,. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1980.
34. Starkman JS, Duffy JW, Wolter CE, Kaufman MR, Scarpero HM, Dmochowski RR,. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol 2008; 179: 1018-1023.
35. Amundsen CL, Romero AA, Jamison MG, Webster GD,. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 2005; 66: 746-750. (Pubitemid 41440816)
36. Foster RT, Anoia EJ, Webster GD, Amundsen CL,. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hour pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn 2007; 26: 213-217. (Pubitemid 46595720)